Plus inc. posted strong Q3 FY 2026 results last month, with 24.6% YoY sales growth and accelerating operating leverage. Click here to read why PLUS is a Buy.
Overview of the main subjects to be discussed at meetings of the Council of the EU over the next two weeks and upcoming media events. General Secretariat of the Council Weekly schedule of President ...
Correspondence to Professor Paul William Hodges, Centre of Clinical Research Excellence in Spinal Pain, Injury and Health, School of Health and Rehabilitation Sciences, The University of Queensland, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results